TRCT
ADAG

Tower Research Capital (TRC)’s Adagene ADAG Stock Holding History

Tower Research Capital (TRC)’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.44K Buy
+1,058
New +$3.98K ﹤0.01% 4386
2022
Q3 		– Sell
-3,627
Closed -$7K – 6014
2022
Q2 		$7K Sell
3,627
-1,365
-27% -$4.13K ﹤0.01% 4755
2022
Q1 		$17K Buy
4,992
+3,714
+291% +$23.4K ﹤0.01% 3670
2021
Q4 		$10K Buy
+1,278
New +$13.1K ﹤0.01% 4528

Other funds holding ADAG

JT
Jupiter Topco New York $245B AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Tower Research Capital (TRC)'s ADAG Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Adagene (ADAG) in Q2 2026: 1,058 shares worth $4.44K. The stake represents ﹤0.01% of the portfolio and ranks #4386 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in ADAG as recently as Q2 2022.

Tower Research Capital (TRC) first reported a position in ADAG in Q4 2021 and has held it in 4 quarters since. The position peaked at $17K in Q1 2022. 35 funds tracked by Wall St. Rank hold ADAG as of Q2 2026.

  • Tower Research Capital (TRC) held 1,058 shares of Adagene worth $4.44K as of Q2 2026.
  • Adagene was a new Tower Research Capital (TRC) position in Q2 2026.
  • Adagene made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4386 holding.
  • Tower Research Capital (TRC) first reported a position in Adagene in Q4 2021 and has held it in 4 quarters since.
  • Tower Research Capital (TRC)'s Adagene position peaked at $17K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Adagene as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.